PlainRecalls
FDA Drug Moderate Class II Terminated

0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.

Reported: July 19, 2017 Initiated: July 6, 2017 #D-0957-2017

Product Description

0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.

Reason for Recall

Lack of Assurance of Sterility: Customer complaints for leaking bags.

Details

Units Affected
131,904 bags
Distribution
Nationwide in USA
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.. Recalled by Baxter Healthcare Corporation. Units affected: 131,904 bags.
Why was this product recalled?
Lack of Assurance of Sterility: Customer complaints for leaking bags.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2017. Severity: Moderate. Recall number: D-0957-2017.